These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 15010391)
21. Isolated tumefactive demyelinating lesions: diagnosis and long-term evolution of 16 patients in a multicentric study. Siri A; Carra-Dalliere C; Ayrignac X; Pelletier J; Audoin B; Pittion-Vouyovitch S; Debouverie M; Lionnet C; Viala F; Sablot D; Brassat D; Ouallet JC; Ruet A; Brochet B; Taillandier L; Bauchet L; Derache N; Defer G; Cabre P; de Seze J; Lebrun Frenay C; Cohen M; Labauge P J Neurol; 2015 Jul; 262(7):1637-45. PubMed ID: 25929666 [TBL] [Abstract][Full Text] [Related]
22. [Application of 1H-magnetic resonance spectroscopy in differential diagnosis of brain low-grade gliomas and demyelinating diseases]. Hou XY; Gao PY Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Apr; 31(2):206-9. PubMed ID: 19507601 [TBL] [Abstract][Full Text] [Related]
23. Plaque-like demyelination in acute disseminated encephalomyelitis (ADEM) - an autopsy case report. Guenther AD; Munoz DG Clin Neuropathol; 2013; 32(6):486-91. PubMed ID: 23863345 [TBL] [Abstract][Full Text] [Related]
24. Distinguishing tumefactive demyelinating lesions from glioma or central nervous system lymphoma: added value of unenhanced CT compared with conventional contrast-enhanced MR imaging. Kim DS; Na DG; Kim KH; Kim JH; Kim E; Yun BL; Chang KH Radiology; 2009 May; 251(2):467-75. PubMed ID: 19261924 [TBL] [Abstract][Full Text] [Related]
25. Clinical and imaging correlation in patients with pathologically confirmed tumefactive demyelinating lesions. Tremblay MA; Villanueva-Meyer JE; Cha S; Tihan T; Gelfand JM J Neurol Sci; 2017 Oct; 381():83-87. PubMed ID: 28991721 [TBL] [Abstract][Full Text] [Related]
27. Meningeal inflammation and demyelination in a patient clinically diagnosed with acute disseminated encephalomyelitis. Koshihara H; Oguchi K; Takei Y; Kitazawa K; Higuchi K; Ohara S J Neurol Sci; 2014 Nov; 346(1-2):323-7. PubMed ID: 25216555 [TBL] [Abstract][Full Text] [Related]
28. Characterization of tumefactive demyelinating lesions using MR imaging and in-vivo proton MR spectroscopy. Malhotra HS; Jain KK; Agarwal A; Singh MK; Yadav SK; Husain M; Krishnani N; Gupta RK Mult Scler; 2009 Feb; 15(2):193-203. PubMed ID: 19181773 [TBL] [Abstract][Full Text] [Related]
29. Tumefactive demyelinating lesions: A literature review of recent findings. Al Malik YM Neurosciences (Riyadh); 2024 Jul; 29(3):153-160. PubMed ID: 38981633 [TBL] [Abstract][Full Text] [Related]
30. Contralateral recurrence of tumefactive demyelination. Khan MN; Guranda M; Essig M Neuroradiol J; 2015 Oct; 28(5):493-7. PubMed ID: 26427896 [TBL] [Abstract][Full Text] [Related]
31. Acute disseminated encephalomyelitis or multiple sclerosis: can the initial presentation help in establishing a correct diagnosis? Dale RC; Branson JA Arch Dis Child; 2005 Jun; 90(6):636-9. PubMed ID: 15908633 [TBL] [Abstract][Full Text] [Related]
32. Spectroscopic magnetic resonance imaging of a tumefactive demyelinating lesion. Law M; Meltzer DE; Cha S Neuroradiology; 2002 Dec; 44(12):986-9. PubMed ID: 12483443 [TBL] [Abstract][Full Text] [Related]
37. A case of demyelinating disease with clinical and radiological features mimicking cerebral tumor. Shih TY; Wan CL; Chen L J Formos Med Assoc; 1994 Feb; 93(2):173-5. PubMed ID: 7912591 [TBL] [Abstract][Full Text] [Related]
38. In vivo differentiation of astrocytic brain tumors and isolated demyelinating lesions of the type seen in multiple sclerosis using 1H magnetic resonance spectroscopic imaging. De Stefano N; Caramanos Z; Preul MC; Francis G; Antel JP; Arnold DL Ann Neurol; 1998 Aug; 44(2):273-8. PubMed ID: 9708554 [TBL] [Abstract][Full Text] [Related]